Is Lurbinectedin a domestic drug or an imported drug and how to purchase it

Lurbinectedin is an anti-tumor drug mainly used for the treatment of specific types of tumors such as small cell lung cancer. According to the current market conditions, Rubicatin is an imported drug and no domestic version has yet been launched. This means that when patients use drugs domestically, they need to obtain them through formal imported drug channels to ensure drug quality and safety. Original drug manufacturers implement strict international GMP standards during drug research and development, clinical trials and production to ensure drug efficacy and reliability.

In the domestic market, the original drug Rubicatin has been approved for marketing, but its specific retail price has not yet been made public. Because it is an imported drug, the price may be affected by factors such as tariffs, transportation costs, and exchange rate fluctuations, so the cost of purchasing drugs is higher. When choosing purchase channels, patients should give priority to regular hospitals, authorized pharmacies or state-approved imported drug channels, and avoid obtaining drugs through informal channels to reduce medication risks.

In the Hong Kong market, the price of Rubicatin original drug is relatively high, about more than RMB 20,000 per box of 4 mg. This price will fluctuate depending on the exchange rate and pharmacy policies. In overseas markets, the price of the American version of Rubicon is about RMB 90,000, while the price of the Singapore version is about RMB 30,000. There is also a big price difference. At present, there are no generic drugs of Rubicatin on the market overseas, which means that the original drug is still the main source of supply and is expensive.
When purchasing Rubicatin, patients and their families should pay attention to the drug packaging, production batch number and expiration date to ensure that the source is formal and reliable. At the same time, considering that drugs are expensive, patients can reasonably plan the treatment cycle according to the doctor's recommendations and conduct economic evaluations in conjunction with medical insurance or other reimbursement policies. In clinical use, strictly follow doctor's instructions to ensure medication safety and maximize efficacy.
Reference: https://www.drugs.com/